Affiliation:
1. Department of Otorhinolaryngologic, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200125, China
Abstract
To determine the effect and mechanism of Insulin-like growth factor 1 (IGF-1) on papillary thyroid carcinoma (PTC) cells. We use TPC-1, one of PTC cell lines to evaluate the effects of IGF-1. SiRNA is used to reduce the effect of IGF-1R. In this study, TPC-1 cells were treated with
recombinant human IGF-1, and the effects of IGF-1 on proliferation, migration, invasion and apoptosis of TPC-1 cells were studied by using Cell counting kit-8, 5-ethynyl-2′-deoxyuridine, colony formation, Transwell assay and flow cytometry. Compared with the control group, the proliferation
ability of TPC-1 cells stimulated by IGF-1 was significantly increased. Cell cycle and apoptosis are not affected by IGF-1. IGF-1 enhances the ability of migration and invasion of TPC-1 cells. The expression of MMP2 increased and the expression of p53 decreased after IGF-1 stimulation in TPC-1
cells. After IGF-1 stimulation, the proliferation, migration and invasion ability of TPC-1 cells were enhanced. MMP2 and p53 may play an important role in proliferation and migration. This may provide a new therapeutic target for patients with PTC.
Publisher
American Scientific Publishers
Subject
General Materials Science
Reference24 articles.
1. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death;Weng;Human Molecular Genetics,2001
2. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995;Hundahl;Cancer,1998
3. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005;Chen;Cancer,2009
4. Optimal surgery for papillary thyroid carcinoma;Udelsman;World Journal of Surgery,1996
5. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma;Pelizzo;Minerva Endocrinologica,2008